Floatz logo

cd22 car-transduced t cells

Acute Lymphoblastic Leukemia, Pediatric

University Hospital TuebingenCell therapyPhase 1/2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

70 Active assets in the Acute Lymphoblastic Leukemia, Pediatric cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB
MERCAPTOPURINE ANHYDROUS
Children's Oncology Group
Phase 3BBB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 3BBB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB
METHOTREXATE
Children's Oncology Group
Phase 3BBB

View all 50 →

Same molecule, other indications

cd22 car-transduced t cells is also rated in:

B-cell acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
B-cell adult acute lymphocytic leukemiaDormant
BB
Indicative ·
64 / 100
View asset →
Lymphoma, B-CellDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →